MOESM4 of Comparative pharmacokinetics and pharmacodynamics of intravenous artelinate versus artesunate in uncomplicated Plasmodium coatneyi-infected rhesus monkey model

Additional file 4. Parasite-time profiles and recrudescence (R) day following once daily dose of IV AL 11.8, 5.6, 5.6 mg kg−1 and IV AS 8.0, 4, 4 mg kg−1 for 3 days, showing mean and 95 % confidence in plasma of P. coatneyi infected rhesus monkeys including quinine control for each treatment and percentage (mean and 95 %CI) of parasite reduction after treatment.